Article Information
History
- September 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sarah M. Hicks1,*,
- Kai Pohl2,3,*,
- Teresa Neeman4,
- Hayley A. McNamara2,
- Kate M. Parsons5,
- Jin-shu He5,
- Sidra A. Ali1,
- Samina Nazir1,
- Louise C. Rowntree6,
- Thi H. O. Nguyen6,
- Katherine Kedzierska6,
- Denise L. Doolan7,
- Carola G. Vinueas2,8,9,
- Matthew C. Cook2,9,
- Nicholas Coatsworth10,11,
- Paul S. Myles12,13,
- Florian Kurth3,
- Leif E. Sander3,
- Graham J. Mann1,
- Russell L. Gruen14,
- Amee J. George1,5,
- Elizabeth E. Gardiner1,†,
- Ian A. Cockburn2,†,#,
- the SARS-CoV-2 Testing in Elective Surgery Collaborators15
- 1ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
- 2Department of Immunology and Infectious Disease, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
- 3Department of Infectious Diseases and Respiratory Medicine, Charité, Universitatsmedizin Berlin, Berlin, Germany
- 4Biological Data Science Institute, John Curtin School of Medical Research, The Australian National University, Canberra, Australia
- 5ANU Centre for Therapeutic Discovery, The Australian National University, Canberra, Australia
- 6Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, Australia
- 7Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia
- 8China Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Jiaotong University, Shanghai, China
- 9Department of Immunology Canberra Hospital, Canberra, Australia
- 10ANU Medical School, Australian National University, Canberra, Australia
- 11The Canberra Hospital, Infectious Diseases, Canberra, Australia
- 12Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Australia
- 13Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Australia
- 14College of Health and Medicine, Australian National University, Canberra, Australia
- 15See Supplementary Text
- ↵#Corresponding Author Contact Details: ian.cockburn{at}anu.edu.au +61 (0)2 6125 4619 Department of Immunology and Infectious Disease, John Curtin School of Medical Research,The Australian National University, Canberra, Australia
Posted September 14, 2020.
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting
